Drug
Acipimox clinical trials
Also written Olbetam.
- studies test it
- 20
- open now
- 1
- in phase 3
- 3
- first study started
- 2002
Keep track of what changes. Save the acipimox studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2011 (4)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 3 |
| 2018 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 6
- Phase 3
- 3
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 19
University of Aarhus (7) · Brigham and Women's Hospital (2) · University of Colorado, Denver (2) · Liverpool John Moores University (1) · Royal Devon and Exeter NHS Foundation Trust (1) · Medical University of Vienna (1) · Massachusetts General Hospital (1) · Boehringer Ingelheim (1)
Often tested with
Tested in the same studies.
Ghrelin (1) · Ritobegron ethyl (1) · Ritobegron (1) · Bisoprolol (1) · Propranolol (1) · Growth Hormone (1)
Studies
Open first, then newest update. How each study uses acipimox is read from its arms, and is right about nine times in ten.
Testing it · 20
- Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in BulimiaEnrolling by invitationPhase 2Charles University, Czech RepublicNCT03338387Written as Acipimox
- Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?CompletedNot applicableLiverpool John Moores UniversityNCT03809793Written as Acipimox 250 MG
- The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic SyndromeCompletedPhase 2/3Brigham and Women's HospitalNCT00759291Written as acipimox
- Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 DiabetesCompletedPhase 3University of Colorado, DenverNCT01816165Written as Acipimox
- Evaluating the Effects of a Study Medication on Exercise Function in Type 2 DiabetesCompletedNot applicableUniversity of Colorado, DenverNCT01580813Written as Acipimox
- Lipolytic Effects of GH in Hypopituitary Patients in VivoCompletedNot applicableUniversity of AarhusNCT02782208Written as Acipimox
- Increasing Mitochondrial Function on Skeletal Muscle Performance in Older MenCompletedNot applicableRoyal Devon and Exeter NHS Foundation TrustNCT02792621Written as Acipimox
- Assessing the Effects of Increased Mitochondrial Function Exercise Training on Muscle PerformanceTerminatedNot applicableUniversity of ExeterNCT03325491Written as Acipimox
- Free Fatty Acids and Vascular Function in Subjects With DiabetesCompletedPhase 1/2Brigham and Women's HospitalNCT00153179Written as acipimox
- The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 SecretionCompletedNot applicableUniversity of AarhusNCT02796950Written as Acipimox
- The Effect of Pharmacological Antilipolysis on the Metabolic Effects of GhrelinCompletedNot applicableUniversity of AarhusNCT01209416Written as Acipimox
- The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 DiabetesCompletedPhase 2/3Medical University of ViennaNCT01980524Written as acipimox
- Effects of Acipimox on Mitochondrial Function in ObesityCompletedPhase 2Massachusetts General HospitalNCT01488409Written as Acipimox
- In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02256722Written as Acipimox
- The Relationship Between Body Composition and Growth Hormone, SIRT Signaling, Protein Turnover and Insulin SensitivityCompletedNot applicableUniversity of AarhusNCT01299831Written as Olbetam
- Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVCompletedNot applicableNational Heart, Lung, and Blood Institute (NHLBI)NCT00246402Written as Acipimox
- Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial FunctionCompletedNot applicableMaastricht University Medical CenterNCT00943059Written as Acipimox
- Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During ExerciseCompletedNot applicableUniversity of AarhusNCT01260376Written as Acipimox
- Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart FailureCompletedNot applicableUniversity of AarhusNCT00549614Written as acipimox
- Metabolic Modulation as Treatment in Acute Heart FailureTerminatedPhase 2University of AarhusNCT00449423Written as acipimox
Given in every arm · 1 — acipimox is usual care beside what is tested
Codes
What other systems call acipimox · ClinicalTrials.gg INT002860
- MeSH (NLM) C027696acipimoxConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) K9AY9IR2SDACIPIMOXConfirmed FDA, NLM, Wikidata
- RxNorm 16817Confirmed FDA, Wikidata
- Wikidata Q2342544acipimoxConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C72982AcipimoxOne source FDA
- DrugBank DB09055One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C027696 | acipimox | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | K9AY9IR2SD | ACIPIMOX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 16817 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2342544 | acipimox | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C72982 | Acipimox | One source FDA |
| DrugBank | DB09055 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.